Consortium Commits 10 Companies To Publicize SNP Results
Executive Summary
The SNP Consortium unveiled April 15 with funding from the Wellcome Trust and 10 major pharmaceutical companies completes over a year of discussions between the academic, industrial and government research communities over commercialization of the genomic research tool and pre-empts a potential flashpoint for the drug industry.
You may also be interested in...
Biomarker Working Group To Explore Development Of Guidance
An FDA working group will be formed by year-end to consider the development of a guidance on biomarkers
Biomarker Working Group To Explore Development Of Guidance
An FDA working group will be formed by year-end to consider the development of a guidance on biomarkers
SNP Consortium's Next Focus Could Be Drug Safety, Bristol Exec Suggests
The pharmaceutical industry SNP consortium's next focus should be on data that could help minimize side effects, Bristol-Myers Squibb Senior VP-Early Discovery & Applied Technology Elliot Sigal, MD/PhD, suggested.